Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|11|977-980

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.11, 2002-05, pp. : 977-980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised Trial of Two Different Daily Doses of Interferon- versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C

By Montalto G.  

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite

Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C

By Jansen Peter LM   De Bruijne Joep  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Arguedas M.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 477-479

Adis International

Access to resources Recommend Favorite

Acetylcysteine Therapy for Chronic Hepatitis C: Are its Effects Synergistic with Interferon Alpha? A Pilot Study

By Tripi S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 297-302

Adis International

Access to resources Recommend Favorite